0 (0%)		09-27 09:29
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	17.78	1-year :	18.24
Resists	First :	15.22	Second :	15.61
Pivot price	14.95
Supports	First :	14.57	Second :	12.13
MAs	MA(5) :	14.72	MA(20) :	14.96
	MA(100) :	15.79	MA(250) :	16.15
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	10.8	D(3) :	9.9
RSI	RSI(14): 32
52-week	High :	19.19	Low :	13.76

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ IFN ] has closed above bottom band by 9.7%. Bollinger Bands are 19.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	14.73 - 14.82	14.82 - 14.91
Low:	14.34 - 14.47	14.47 - 14.59
Close:	14.47 - 14.66	14.66 - 14.84

Fri, 26 Sep 2025
Disseminated Mycobacterium kansasii disease complicating Talaromyces marneffei infection in patient with anti-IFN-γ autoantibodies: a case report - BMC Infectious Diseases

Tue, 19 Aug 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19 - ScienceDirect.com

Fri, 18 Jul 2025
IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures | Cell Death & Disease - Nature

Tue, 01 Jul 2025
Increased IFN responses drive myeloid cell activation in people living with HIV-1 - Nature

Tue, 20 May 2025
Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice - Nature

Wed, 26 Mar 2025
An atlas of protein phosphorylation dynamics during interferon signaling - PNAS

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	40 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	15.2 (%)
Shares Short	137 (K)
Shares Short P.Month	122 (K)

EPS	3.17
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	17.29
Profit Margin	-169.9 %
Operating Margin	-48.4 %
Return on Assets (ttm)	-0.4 %
Return on Equity (ttm)	-1.4 %
Qtrly Rev. Growth	17.2 %
Gross Profit (p.s.)	0.14
Sales Per Share	0.14
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	4.62
PEG Ratio	0
Price to Book value	0.84
Price to Sales	103.52
Price to Cash Flow	0

Dividend	0.43
Forward Dividend	0
Dividend Yield	2.9%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.